The RelB-BLNK Axis Determines Cellular Response to a Novel Redox-Active Agent Betamethasone during Radiation Therapy in Prostate Cancer

Aberrant levels of reactive oxygen species (ROS) are potential mechanisms that contribute to both cancer therapy efficacy and the side effects of cancer treatment. Upregulation of the non-canonical redox-sensitive NF-kB family member, RelB, confers radioresistance in prostate cancer (PCa). We screen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaiswing, Luksana, Xu, Fangfang, Zhao, Yanming, Thorson, Jon, Wang, Chi, He, Daheng, Lu, Jinpeng, Ellingson, Sally R., Zhong, Weixiong, Meyer, Kristy, Luo, Wei, St. Clair, William, Clair, Daret St.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223669/
https://www.ncbi.nlm.nih.gov/pubmed/35742868
http://dx.doi.org/10.3390/ijms23126409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223669/
https://www.ncbi.nlm.nih.gov/pubmed/35742868
http://dx.doi.org/10.3390/ijms23126409

Ejemplares similares